Results 181 to 190 of about 4,744 (194)

Impact of DPYD, DPYS, and UPB1 gene variations on severe drug-related toxicity in patients with cancer

Cancer Science, 2020
Katsuyuki Yokoi, Hiroki Kurahashi, Yasuko Shinkai   +2 more
exaly  

Effectiveness and safety of reduced-dose fluoropyrimidine therapy in patients carrying the DPYD*2A variant: A matched pair analysis

International Journal of Cancer, 2019
Jan H M Schellens, Maarten J Deenen, Anthonius de Boer   +2 more
exaly  

Suppression of DPYD expression in RKO Cells via DNA methylation in the regulatory region of the DPYD promoter: a potentially important epigenetic mechanism regulating DPYD expression

Biochemistry and Cell Biology, 2007
Richie Soong, James R Davie, Robert B Diasio   +2 more
exaly  

Prospective DPYD genotyping to reduce the risk of fluoropyrimidine-induced severe toxicity: Ready for prime time

European Journal of Cancer, 2016
Jan H M Schellens, Hans J. Gelderblom, Jesse J Swen   +2 more
exaly  

DPYD Pharmacogenetics: To Opt-in or to Opt-out

JCO Oncology Practice
Bani Tamraz, Alan P. Venook
openaire   +2 more sources

Evaluation of Clinical Implementation of Prospective DPYD Genotyping in 5-Fluorouracil- or Capecitabine-Treated Patients

Pharmacogenomics, 2016
Hans J. Gelderblom, Jesse J Swen, Henk-Jan Guchelaar   +2 more
exaly  

Dihydropyrimidine Dehydrogenase (DPYD, 1p22)

2008
openaire   +1 more source

Lack of large intragenic rearrangements in dihydropyrimidine dehydrogenase (DPYD) gene in fluoropyrimidine-treated patients with high-grade toxicity

Cancer Chemotherapy and Pharmacology, 2009
Petra Kleiblova, Ivana Struzinska, Zdeněk Kleibl   +2 more
exaly  

DPYD gene variants and use thereof

2010
WAGNER SUSANNE, POTTER JENNIFER
openaire   +3 more sources

Influence of DPYD gene polymorphisms on 5-Fluorouracil toxicities in Thai colorectal cancer patients

Cancer Chemotherapy and Pharmacology
Natchaya Vanwong, Chonlaphat Sukasem, Nipaporn Sankuntaw   +2 more
exaly